REGENXBIO Inc. (RGNX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for REGENXBIO Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$7.24
+9.70% today
Market cap
$436M
Overall quality
—
Kronos AI 30-day
+23.1%
8 of 8 simulated paths end higher
REGENXBIO Inc. (RGNX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $436M. It trades at $7.24, up 9.70% today. 11 analysts' average target of $21.73 implies +200.1% from today's price. Kronos AI's 30-day forecast is +23.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $21.73 |
| Low – high | $10.00 – $42.00 |
| Analysts | 11 |
| Upside to average | +200.1% |
Kronos AI 30-day forecast
| Expected close | $8.13 (+23.1%) |
| Likely range | +17.1% … +29.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.